Preparation of magnetic solid liposome nanoparticles of paclitaxel

Yaoxue Xuebao

Volumn 41, Issue 10, 2006, Pages 933-938

  Xin, Sheng Chang ^a,b   Wu, Xin Rong ^a,b   Zhou, Li Zhen ^b  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Liposome; Magnetic; Paclitaxel; Target; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; LIPOSOME; MAGNETITE; NANOPARTICLE; PACLITAXEL;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; METHODOLOGY; PARTICLE SIZE; PH; TEMPERATURE; ULTRASOUND;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EMULSIONS; FERROSOFERRIC OXIDE; HYDROGEN-ION CONCENTRATION; LIPOSOMES; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; TEMPERATURE; ULTRASONICS;

EID: 33845357832     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ruel-Gariepy E, Shive M, Biohara A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel [J], Eur J Pharm Biopharm, 2004, 57:53-63.
2. Islam MN, Song YQ, Iskander MN. Investigation of structural requirements of anticancer activity at the paclitaxel/tubulin binding site using CoMFA and CoMSIA [J]. J Mol Graph Model, 2003, 21:263-272.
3. Singla AK, Garg A, Aggarwa D, et al. Paclitaxel and its formulation [J]. Int J Pharm, 2002, 235:179.
4. Shi B, Pei YY. Research progress on paolitaxel and it' s dosage [J]. J Chin Clin Pharm, 2004, 13:389-392.
5. Zhang ZX, Zhang HX, Yang QL. Advances on research and development of taxol analogues [J]. Nat Prod Res Dev, 2005, 7:810-817.
6. Xie J, Wang CH. Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel [J]. Pharm Res, 2005, 22:2079-2090.
7. Zhang Q, Wu FL. Pharmaceutics [M]. Beijing: Peking University Medical Press, 2005:470-478.
8. Song HF, Ma J, Lin C. Cancer target treatment with magnetic drug targeting [J]. Foreign Med Sci (Cancer Sect), 2002, 29:183-186.
9. 4 magnetic nanoparticles and magneticfluids [D]. Chengdui: Master's Degree Paper of Sichuan University, 2003:53-62.
10. Lübbe AS, Bergemann C, Huhut W, et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy [J]. Cancer Res, 1996, 56:4694-4701.
11. Votairas PA. Hydrodynamics of magnetic drug targeting [J]. J Biomech, 2002, 35:813-821.
12. Xu HB, Yang XL. Nanoparticles Drug [M]. Beijing: Tsinghua University Press, 2004:245-265.